Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Paxmedica Inc (NQ: PXMD )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.3700 (14)
Ask (Size) 0.3702 (10)
Prev. Close 0.6883
Today's Range N/A - N/A
52wk Range 0.3720 - 1.290
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA
Via Investor Brand Network
Study Discovers Elevated Risk of Toxicity Among Autistic Kids
Via Investor Brand Network

Performance

More News

Read More
PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments
Via Investor Brand Network
Researcher Wants to Untangle Environmental, Genetic Complexities of Autism
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Appeals NASDAQ Delisting Decision, Prepares for June FDA Meeting
Via Investor Brand Network
Exposures Product Safety
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
From PaxMedica, Inc.
Via GlobeNewswire
PXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024
Via InvestorPlace
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Continues Advancement of PAX-101 Regulatory Strategy
Via Investor Brand Network
Exposures Product Safety
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
From PaxMedica, Inc.
Via GlobeNewswire
PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Latest Bell2Bell Podcast Release
Via Investor Brand Network
“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101
Via Investor Brand Network
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
From PaxMedica, Inc.
Via GlobeNewswire
Misinformation on TikTok Causing Many to Misdiagnose Themselves as Autistic
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry
Via Investor Brand Network
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
From PaxMedica, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.